Ovid Therapeutics announces promising early-stage data for its novel treatment targeting rare neurological conditions. The company is preparing for upcoming investor calls to discuss pipeline advancements.
Ovid Therapeutics is a biopharmaceutical company focused on developing novel therapeutics for neurological disorders.
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing